187 related articles for article (PubMed ID: 32143894)
21. Human genetic polymorphisms and risk of viral infection after solid organ transplantation.
Redondo N; Navarro D; Aguado JM; Fernández-Ruiz M
Transplant Rev (Orlando); 2022 Jan; 36(1):100669. PubMed ID: 34688126
[TBL] [Abstract][Full Text] [Related]
22. Varicella zoster virus in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Pergam SA; Limaye AP;
Clin Transplant; 2019 Sep; 33(9):e13622. PubMed ID: 31162727
[TBL] [Abstract][Full Text] [Related]
23. Viral pneumonia in recipients of solid organ transplants.
Anderson DJ; Jordan MC
Semin Respir Infect; 1990 Mar; 5(1):38-49. PubMed ID: 2160718
[TBL] [Abstract][Full Text] [Related]
24. Clinical and virologic outcomes in high-risk adult Epstein-Barr virus mismatched organ transplant recipients.
Kumar D; Patil N; Husain S; Chaparro C; Bhat M; Kim SJ; Humar A
Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28489256
[TBL] [Abstract][Full Text] [Related]
25. Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation.
Ma CK; Blyth E; Clancy L; Simms R; Burgess J; Brown R; Deo S; Micklethwaite KP; Gottlieb DJ
Cytotherapy; 2015 Oct; 17(10):1406-20. PubMed ID: 26349000
[TBL] [Abstract][Full Text] [Related]
26. Herpes virus infections: clinical manifestations and therapeutic strategies in immunocompromised patients.
Saral R; Burns WH; Prentice HG
Clin Haematol; 1984 Oct; 13(3):645-60. PubMed ID: 6094062
[TBL] [Abstract][Full Text] [Related]
27. High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders.
Baldanti F; Grossi P; Furione M; Simoncini L; Sarasini A; Comoli P; Maccario R; Fiocchi R; Gerna G
J Clin Microbiol; 2000 Feb; 38(2):613-9. PubMed ID: 10655355
[TBL] [Abstract][Full Text] [Related]
28. A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder.
Humar A; Hébert D; Davies HD; Humar A; Stephens D; O'Doherty B; Allen U
Transplantation; 2006 Mar; 81(6):856-61. PubMed ID: 16570008
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of multiplex real-time PCR assays for rapid detection of cytomegalovirus, Epstein-Barr virus, and polyomavirus BK in whole blood from transplant candidates.
Hwang KA; Ahn JH; Nam JH
J Microbiol; 2018 Aug; 56(8):593-599. PubMed ID: 30047089
[TBL] [Abstract][Full Text] [Related]
30. Infections in solid-organ transplant recipients.
Patel R; Paya CV
Clin Microbiol Rev; 1997 Jan; 10(1):86-124. PubMed ID: 8993860
[TBL] [Abstract][Full Text] [Related]
31. Cytomegalovirus in solid organ transplantation.
Rubin RH
Transpl Infect Dis; 2001; 3 Suppl 2():1-5. PubMed ID: 11926743
[TBL] [Abstract][Full Text] [Related]
32. Prevention and early treatment of opportunistic viral infections in patients with leukemia and allogeneic stem cell transplantation recipients.
Angarone M; Ison MG
J Natl Compr Canc Netw; 2008 Feb; 6(2):191-201. PubMed ID: 18319051
[TBL] [Abstract][Full Text] [Related]
33. Virus-specific T-cell therapy in solid organ transplantation.
Roemhild A; Reinke P
Transpl Int; 2016 May; 29(5):515-26. PubMed ID: 26284570
[TBL] [Abstract][Full Text] [Related]
34. Treatment of alpha and beta herpesvirus infections in solid organ transplant recipients.
Abad CL; Razonable RR
Expert Rev Anti Infect Ther; 2017 Feb; 15(2):93-110. PubMed ID: 27911112
[TBL] [Abstract][Full Text] [Related]
35. The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation.
Green M; Reyes J; Webber S; Rowe D
Transpl Infect Dis; 2001 Jun; 3(2):97-103. PubMed ID: 11395975
[TBL] [Abstract][Full Text] [Related]
36. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease.
Razonable RR; Brown RA; Humar A; Covington E; Alecock E; Paya CV;
J Infect Dis; 2005 Oct; 192(8):1331-9. PubMed ID: 16170749
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus encephalitis in solid organ transplantation.
Lau JSY; Low ZM; Abbott I; Shochet L; Kanellis J; Kitching AR; Korman TM
New Microbiol; 2017 Jul; 40(3):212-217. PubMed ID: 28513810
[TBL] [Abstract][Full Text] [Related]
38. Antiviral T-Cell Frequencies in a Healthy Population: Reference Values for Evaluating Antiviral Immune Cell Profiles in Immunocompromised Patients.
Schulze Lammers FC; Bonifacius A; Tischer-Zimmermann S; Goudeva L; Martens J; Lepenies B; von Karpowitz M; Einecke G; Beutel G; Skripuletz T; Blasczyk R; Beier R; Maecker-Kolhoff B; Eiz-Vesper B
J Clin Immunol; 2022 Apr; 42(3):546-558. PubMed ID: 34989946
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus lymphoproliferative disease after solid organ transplantation.
Prockop SE; Vatsayan A
Cytotherapy; 2017 Nov; 19(11):1270-1283. PubMed ID: 28965834
[TBL] [Abstract][Full Text] [Related]
40. Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature.
Ramos-Casals M; Cuadrado MJ; Alba P; Sanna G; Brito-Zerón P; Bertolaccini L; Babini A; Moreno A; D'Cruz D; Khamashta MA
Medicine (Baltimore); 2008 Nov; 87(6):311-318. PubMed ID: 19011502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
